Revvity, Inc. Common Stock (NY:RVTY)

Tech Stocks Rally, Gold Tumbles On US-China Trade Progress: What's Moving Markets Monday? ↗

October 27, 2025

Wall Street extended its record-setting streak on Monday, with major large-cap indices logging a third consecutive session of strong gains after a breakthrough in trade negotiations between Washington...

Via Benzinga

What's going on in today's session: S&P500 gap up and gap down stocks ↗

October 27, 2025

Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Monday and stay ahead of the market trends.

Via Chartmill

Revvity Earnings Preview ↗

October 24, 2025

Via Benzinga

What Analysts Are Saying About Revvity Stock ↗

October 02, 2025

Via Benzinga

Is Revvity Gaining or Losing Market Support? ↗

September 10, 2025

Via Benzinga

Which S&P500 stocks are moving before the opening bell on Monday? ↗

October 27, 2025

Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Revvity Lifts Profit Outlook, Launches $1 Billion Buyback Plan ↗

October 27, 2025

Revvity Inc. (NYSE: RVTY) announced mixed Q3 results, beating EPS but missing revenue estimates, leading to a decline in stock price.

Via Benzinga

Revvity Inc (NYSE:RVTY) Q3 2025 Earnings: EPS Beats Estimates, Revenue Falls Short ↗

October 27, 2025

Revvity's Q3 2025 earnings beat EPS estimates but revenue was slightly below forecasts. The company announced a new $1 billion share buyback program.

Via Chartmill

Topics Earnings

Revvity (NYSE:RVTY) Posts Q3 Sales In Line With Estimates

October 27, 2025

Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 2.2% year on year to $698.9 million. The company’s outlook for the full year was close to...

Revvity Announces Financial Results for the Third Quarter of 2025

October 27, 2025

From Revvity

Life sciences company Revvity (NYSE:RVTY) will be announcing earnings results this Monday before the bell. Here’s what you need to know.

Earnings Scheduled For October 27, 2025 ↗

October 27, 2025

Via Benzinga

Revvity (RVTY) Q3 Earnings Report Preview: What To Look For

October 25, 2025

Topics Artificial Intelligence

Revvity Board Declares Quarterly Dividend

October 23, 2025

From Revvity

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at research tools & consumables stocks,...

What's Driving the Market Sentiment Around Revvity Inc? ↗

October 21, 2025

Via Benzinga

Research Tools & Consumables Stocks Q2 Teardown: Revvity (NYSE:RVTY) Vs The Rest

October 14, 2025

Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions

Topics Economy

October 14, 2025

Washington D.C. – The Federal Reserve has sent clear signals of a continued dovish pivot, with Chair Jerome Powell indicating the likelihood of two additional quarter-point interest rate cuts before...

Topics Artificial Intelligence Bonds Credit Cards

Revvity Showcases Progress with Purpose in 2025 Impact Report

October 14, 2025

From Revvity

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Medpace and Revvity Stocks Trade Down, What You Need To Know

October 10, 2025

Topics Economy Government World Trade

Revvity to Hold Earnings Call on Monday, October 27, 2025

October 06, 2025

From Revvity

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

1 Profitable Stock to Own for Decades and 2 We Turn Down

October 03, 2025

Topics Economy

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

October 02, 2025

From Revvity

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement...

Topics Artificial Intelligence Economy Government

Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma

September 30, 2025

Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility

Topics Artificial Intelligence Economy Government

September 30, 2025

As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move...

Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

Topics Economy Government Supply Chain

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.

Topics Government

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis

September 29, 2025

From Revvity

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This...

1 Healthcare Stock with Exciting Potential and 2 We Ignore

September 29, 2025

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

Topics Stocks

September 22, 2025

From Revvity

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

1 Oversold Stock Primed to Rebound and 2 We Brush Off

September 12, 2025